{"meta":{"query_hash":"53650d73b94e","filters":{"venue":"Human Vaccines"},"cohort_total":29,"direct_labels_cover":0,"predictions_cover":29,"exported":29,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/53650d73b94e","api":"https://metacan.xera.ac/api/v1/cohort?venue=Human+Vaccines"},"results":[{"id":"W1970117165","doi":"10.4161/hv.6.2.10299","title":"Antibody and immune memory persistence after vaccination of preadolescents with low doses of recombinant hepatitis B vaccine","year":2010,"lang":"en","type":"article","venue":"Human Vaccines","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut National de Santé Publique du Québec","funders":"Merck Canada","keywords":"Titer; Medicine; Vaccination; Booster dose; Booster (rocketry); Hepatitis B; Persistence (discontinuity); Hepatitis B vaccine; Immunology; Antibody; Immune system; Immunological memory; Immunity; Internal medicine; Hepatitis B virus; HBsAg; Virus","score_opus":0.010439866014861467,"score_gpt":0.26680962344140435,"score_spread":0.2563697574265429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970117165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975705,0.0010063219,0.000013857756,0.00017685267,0.00016425295,0.00053008593,0.000011142509,0.000034942528,0.0004920009],"genre_scores_gemma":[0.9983955,0.0005048833,0.00045347816,0.000037164737,0.0000614078,0.000028259403,0.000030482892,0.000032589884,0.00045620732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870664,0.000033209915,0.0004937856,0.0003013056,0.00024702842,0.00021803527],"domain_scores_gemma":[0.99871117,0.000046511836,0.0002809589,0.00042173307,0.0004629843,0.00007662061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016167952,0.00022568078,0.0007125677,0.0001968254,0.000090053414,0.0000099219915,0.00010029507,0.000084885185,0.00031527312],"category_scores_gemma":[0.000084192274,0.00017116417,0.00009624097,0.00017609737,0.000051697392,0.00016504266,0.00009131732,0.00018636456,0.0000037195662],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031410443,0.0003272315,0.86560196,0.0009459445,0.00032451,0.000021111486,0.00084310805,2.433619e-7,0.13053094,0.00003784911,0.000056126333,0.0009968642],"study_design_scores_gemma":[0.0022051649,0.00076294964,0.95638096,0.00046396887,0.00065847184,0.000049251004,0.00010016239,0.000020103518,0.039111093,0.000059618986,0.000023732642,0.00016452787],"about_ca_topic_score_codex":0.0009978043,"about_ca_topic_score_gemma":0.004168581,"teacher_disagreement_score":0.091419846,"about_ca_system_score_codex":0.000016146636,"about_ca_system_score_gemma":0.000035287303,"threshold_uncertainty_score":0.6979872},"labels":[],"label_agreement":null},{"id":"W1970168773","doi":"10.4161/hv.6.3.10298","title":"High titer human immunoglobulin as a specific therapy against West Nile virus encephalitis","year":2010,"lang":"en","type":"article","venue":"Human Vaccines","topic":"Mosquito-borne diseases and control","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Japanese encephalitis; Virology; Disease; Immunology; Virus; Encephalitis; Asymptomatic; Population; Medicine; Antibody; Culex; Flavivirus; Biology; Environmental health; Internal medicine","score_opus":0.014213545713008228,"score_gpt":0.28322751211124525,"score_spread":0.26901396639823705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970168773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885523,0.0022466776,0.000003719957,0.0006479763,0.00057723053,0.00055131136,0.00003680757,0.00018762352,0.00719639],"genre_scores_gemma":[0.9884697,0.00043418555,0.00006583138,0.0016939957,0.0024312106,0.000098222554,0.00024051906,0.00006754023,0.0064987987],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982855,0.00003921282,0.00044114617,0.0004986082,0.00029828688,0.00043728447],"domain_scores_gemma":[0.9985182,0.000030873605,0.00013436562,0.0009063077,0.00016753863,0.00024269287],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00013397237,0.0003302122,0.00047110685,0.00012856293,0.00033391482,0.00012793798,0.00029489503,0.0001484688,0.020228092],"category_scores_gemma":[0.000021169744,0.00026962947,0.00025938253,0.00014377713,0.000060623555,0.00013008423,0.000055961707,0.00036028432,0.0008699308],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043956802,0.0008399722,0.026644187,0.000044153527,0.00017827413,0.00028970212,0.00041283434,9.332214e-7,0.91323215,0.010783613,0.02384245,0.023292158],"study_design_scores_gemma":[0.0073250188,0.0006402227,0.6951665,0.00009266896,0.00007044759,0.000054226937,0.00013595624,0.0000058321725,0.012360741,0.0012232185,0.28242886,0.00049626705],"about_ca_topic_score_codex":0.00068769057,"about_ca_topic_score_gemma":0.00034821933,"teacher_disagreement_score":0.9008714,"about_ca_system_score_codex":0.00002848264,"about_ca_system_score_gemma":0.0000520051,"threshold_uncertainty_score":0.99997556},"labels":[],"label_agreement":null},{"id":"W1971945861","doi":"10.4161/hv.7.4.14141","title":"Acute otitis media and its prevention by immunization: A survey of Canadian pediatricians’ knowledge, attitudes and beliefs","year":2011,"lang":"en","type":"article","venue":"Human Vaccines","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institut National de Santé Publique du Québec","funders":"GlaxoSmithKline","keywords":"Medicine; Acute otitis media; Immunization; Otitis; Medical prescription; Family medicine; Pediatrics; Adverse effect; Multivariate analysis; Pneumococcal conjugate vaccine; Immunology; Antibiotics; Internal medicine; Streptococcus pneumoniae; Surgery","score_opus":0.05734017980258541,"score_gpt":0.3039299727532077,"score_spread":0.2465897929506223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971945861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99374026,0.0033457817,0.0000042261754,0.00008555825,0.000120170786,0.00019665858,0.000059761074,0.000024661658,0.0024229344],"genre_scores_gemma":[0.9974321,0.0014330901,0.000013736562,0.000042424614,0.00008137289,0.0000096924105,0.000085904016,0.000014758509,0.00088690635],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994018,0.000056371242,0.0002034343,0.00014679742,0.000056636167,0.0001349542],"domain_scores_gemma":[0.99939716,0.000033207973,0.00006643766,0.000119057266,0.00021970939,0.00016445197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013506497,0.0001051256,0.00020230566,0.00037860835,0.00016371967,0.000009185832,0.000043362663,0.00008386913,0.00017913558],"category_scores_gemma":[0.000069348906,0.00009405566,0.000023041372,0.00036645768,0.000026917745,0.00009017038,0.000024766065,0.00007793331,0.000007075023],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000092708,0.00013997518,0.98908526,0.00014523989,0.00010267987,0.0000066393413,0.0011799169,4.48803e-8,0.00584623,0.00031477195,0.002706724,0.00046324806],"study_design_scores_gemma":[0.00061425345,0.00020690597,0.9971221,0.000059795166,0.000111351,0.000031726475,0.000021371321,0.0000029440848,0.0007633359,0.00003619754,0.00093957654,0.00009044224],"about_ca_topic_score_codex":0.01356,"about_ca_topic_score_gemma":0.24821758,"teacher_disagreement_score":0.23465757,"about_ca_system_score_codex":0.0000157503,"about_ca_system_score_gemma":0.00009649807,"threshold_uncertainty_score":0.9930088},"labels":[],"label_agreement":null},{"id":"W1992463335","doi":"10.4161/hv.6.4.10867","title":"Development of TNFSF as molecular adjuvants for ALVAC HIV-1 vaccines","year":2010,"lang":"en","type":"article","venue":"Human Vaccines","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Canadian Institutes of Health Research; Ontario HIV Treatment Network","keywords":"Immunogenicity; Medicine; HIV vaccine; Adjuvant; Vaccination; Clinical trial; Immunology; AIDS Vaccines; Vaccine trial; Virology; Human immunodeficiency virus (HIV); Immune system; Internal medicine","score_opus":0.018784717563056875,"score_gpt":0.3033413365913008,"score_spread":0.2845566190282439,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992463335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99687165,0.0006593166,0.00014288205,0.00020031657,0.00029257569,0.00047399406,0.000054488297,0.000051086707,0.0012536858],"genre_scores_gemma":[0.9903173,0.000011805598,0.0029184467,0.000042955086,0.000047150985,0.00015878276,0.0005122182,0.000025339097,0.005966017],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989218,0.00003245299,0.0003277368,0.00028029716,0.00004332145,0.00039440693],"domain_scores_gemma":[0.9993097,0.00006752332,0.00009734794,0.00032643392,0.0001550543,0.000043930573],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00015698788,0.0001896828,0.00029431956,0.00013522911,0.00024386939,0.000010458443,0.0002623346,0.00015170447,0.0018679046],"category_scores_gemma":[0.0000841705,0.00015044928,0.000103105835,0.00007084539,0.000034072284,0.00005165609,0.00008870576,0.00015936529,0.0011315685],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013127008,0.00025466527,0.0043173316,0.000054496828,0.00027898746,0.0000067361807,0.0003677666,3.9280735e-7,0.97613454,0.001691838,0.007559187,0.009202765],"study_design_scores_gemma":[0.0032690777,0.00020397933,0.025532532,0.000024836798,0.00003961206,0.00002378188,0.000105027815,5.7485084e-7,0.80906767,0.00044248407,0.16110267,0.00018775435],"about_ca_topic_score_codex":0.000018433886,"about_ca_topic_score_gemma":0.00021509535,"teacher_disagreement_score":0.1670669,"about_ca_system_score_codex":0.000013340256,"about_ca_system_score_gemma":0.00010216955,"threshold_uncertainty_score":0.9996462},"labels":[],"label_agreement":null},{"id":"W2000061294","doi":"10.4161/hv.7.7.15579","title":"Safety and reactogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 viral-like-particle vaccine in older adolescents and young adults","year":2011,"lang":"en","type":"article","venue":"Human Vaccines","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Center for Research Resources; National Institute of Allergy and Infectious Diseases; University of California, San Francisco","keywords":"Medicine; Reactogenicity; Tolerability; Placebo; Adverse effect; Vaccination; Internal medicine; Incidence (geometry); Randomized controlled trial; Immunology; Immunogenicity; Antibody","score_opus":0.04165342418886398,"score_gpt":0.31942577559278473,"score_spread":0.27777235140392076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000061294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955656,0.0016001236,0.000004571046,0.00007951015,0.00004989204,0.0005666394,0.000010745581,0.000039227954,0.0020836927],"genre_scores_gemma":[0.9988372,0.00042707013,0.000025777657,0.00010808977,0.00010287893,0.00001877597,0.000018895735,0.000031584204,0.00042975735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982381,0.000072948074,0.0005561634,0.00044408656,0.00028829137,0.0004004002],"domain_scores_gemma":[0.9990914,0.000023045375,0.00010690214,0.0003778586,0.00015826197,0.00024253613],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002827598,0.00022875346,0.0005510631,0.00015604206,0.00012392752,0.000015452753,0.00012158149,0.00010622438,0.0021435923],"category_scores_gemma":[0.000044678945,0.0001906653,0.000072721,0.0001909623,0.000060612874,0.00013190079,0.00018585908,0.00023198489,0.000006652257],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021523884,0.0005802037,0.98145175,0.00069788407,0.00004101347,0.000028981405,0.0015390122,8.076877e-8,0.007274747,0.00027894136,0.00027185402,0.005683136],"study_design_scores_gemma":[0.009214015,0.00048837194,0.98167056,0.00026368507,0.00007789763,0.000021921232,0.00022029402,0.00003139191,0.007410102,0.00025377495,0.00016088305,0.00018710917],"about_ca_topic_score_codex":0.0042099776,"about_ca_topic_score_gemma":0.008962378,"teacher_disagreement_score":0.0070616263,"about_ca_system_score_codex":0.00006947567,"about_ca_system_score_gemma":0.000023402336,"threshold_uncertainty_score":0.99876857},"labels":[],"label_agreement":null},{"id":"W2002056847","doi":"10.4161/hv.1.4.1990","title":"Potency of Cell-Mediated Immune Responses to Different Combined HIV-1 Immunogens in a Humanized Murine Model","year":2005,"lang":"en","type":"article","venue":"Human Vaccines","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Potency; Humanized mouse; Immune system; Immunology; Human immunodeficiency virus (HIV); Virology; Biology; In vitro","score_opus":0.019423284431976027,"score_gpt":0.27217852561726674,"score_spread":0.2527552411852907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002056847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961052,0.0018462428,0.000023522149,0.00056604436,0.000049299084,0.0005535248,0.00014759583,0.00006301541,0.00064558664],"genre_scores_gemma":[0.9816982,0.00011392734,0.00012780397,0.000040755534,0.00001661344,0.00010123544,0.0005015914,0.000027051185,0.017372828],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998322,0.00019823798,0.00057628914,0.0003222745,0.00006426251,0.00051693746],"domain_scores_gemma":[0.99913377,0.00012573822,0.0001067392,0.00048333438,0.00009966783,0.000050768813],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00016879388,0.00026331234,0.00053441303,0.00043613193,0.00015494143,0.000010420183,0.00032898557,0.00013273646,0.0013670815],"category_scores_gemma":[0.0000750851,0.00021060997,0.00012322873,0.00018600027,0.00006105219,0.00006007924,0.00018612081,0.00021626014,0.0010518853],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019341761,0.0014625418,0.0104637155,0.000029288218,0.00011704492,0.000014199245,0.00091704325,0.00006713517,0.98306626,0.00019417654,0.0012823744,0.00045207053],"study_design_scores_gemma":[0.022614455,0.0015013046,0.48459932,0.00011720147,0.000070690534,0.000015521266,0.0002841381,0.00016780623,0.4882665,0.00022617109,0.00160465,0.0005322445],"about_ca_topic_score_codex":0.00018801696,"about_ca_topic_score_gemma":0.00038071183,"teacher_disagreement_score":0.49479973,"about_ca_system_score_codex":0.00008941389,"about_ca_system_score_gemma":0.000050990606,"threshold_uncertainty_score":0.99972594},"labels":[],"label_agreement":null},{"id":"W2005791824","doi":"10.4161/hv.7.2.13690","title":"Long term protection against cervical infection with the human papillomavirus: Review of currently available vaccines","year":2011,"lang":"en","type":"review","venue":"Human Vaccines","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"GlaxoSmithKline","keywords":"Bivalent (engine); Immunogenicity; Medicine; Vaccination; Booster dose; Virology; Immune system; Cervical cancer; Immunology; HPV vaccines; HPV infection; Immunization; Internal medicine; Cancer","score_opus":0.14155396687683644,"score_gpt":0.39794047132170157,"score_spread":0.2563865044448651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005791824","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027609928,0.9824143,0.0000090555095,0.000088397916,0.00013014418,0.004350822,0.000014133937,0.00011934949,0.012597665],"genre_scores_gemma":[0.00031043193,0.9941375,0.000005664655,0.0001557804,0.0010683587,0.0009876369,0.00031324377,0.00012718339,0.0028941995],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99669796,0.0003666845,0.0011243781,0.00072587,0.00058023544,0.0005048603],"domain_scores_gemma":[0.9971319,0.00006302959,0.00072699774,0.0011512907,0.00072147464,0.00020531994],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000766437,0.00068243925,0.0025327227,0.00035822543,0.00039508275,0.00005047364,0.00041056634,0.00031199373,0.011468851],"category_scores_gemma":[0.00007744872,0.0003626544,0.000725159,0.000909271,0.00008961811,0.00014806307,0.00020694768,0.0011932947,0.000244997],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048827795,0.00025782784,0.0013887853,0.353411,0.00030480293,0.00001082238,0.000024312796,1.6998083e-8,0.0000068189606,0.00007526066,0.0067358003,0.6377357],"study_design_scores_gemma":[0.0009813838,0.0007851568,0.013621173,0.102615945,0.0023729024,0.00010060595,0.0000031078794,3.4958168e-7,0.000020061738,0.000015616795,0.87905073,0.00043299762],"about_ca_topic_score_codex":0.000339739,"about_ca_topic_score_gemma":0.0006456065,"teacher_disagreement_score":0.87231493,"about_ca_system_score_codex":0.00019627895,"about_ca_system_score_gemma":0.00028352192,"threshold_uncertainty_score":0.9998825},"labels":[],"label_agreement":null},{"id":"W2014047240","doi":"10.4161/hv.6.9.11561","title":"Recent advances in the development of novel mucosal adjuvants and antigen delivery systems","year":2010,"lang":"en","type":"article","venue":"Human Vaccines","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; Institute for Biological Sciences; Brock University","funders":"","keywords":"Adjuvant; Medicine; Mucosal immunity; Immunization; Immunology; Mucosal immunology; Vaccination; Vaccine adjuvant; Immune system; Antigen; Immunity","score_opus":0.021354511710913095,"score_gpt":0.2824016329974406,"score_spread":0.2610471212865275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014047240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927437,0.006414437,0.000047146408,0.000020337748,0.00017897415,0.00011512073,0.0000043305135,0.0000027854658,0.00047319813],"genre_scores_gemma":[0.997203,0.0023137957,0.00023250996,0.00003739722,0.00011280696,0.0000137520465,0.000026516092,0.0000060195925,0.00005423291],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9994204,0.000016576372,0.00020982906,0.00016719165,0.00007056236,0.000115410614],"domain_scores_gemma":[0.9996647,0.000007754528,0.0000663748,0.00017039254,0.00007089508,0.000019887671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016638351,0.00009057227,0.00010277437,0.000036322297,0.00005798689,0.000014890693,0.00017321388,0.00006153647,0.000011248275],"category_scores_gemma":[0.00001647331,0.00006330403,0.000017697277,0.000040105308,0.000021954467,0.000006666151,0.000057888126,0.000063618325,0.000001478505],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000350208,0.0000922092,0.03219146,0.000032634158,0.00001541318,9.374171e-7,0.000372691,0.000009922883,0.9447478,0.000068471345,0.00029785803,0.022135546],"study_design_scores_gemma":[0.0018037874,0.00033510398,0.5107375,0.00008389581,0.00001686601,0.000042412707,0.0019047045,0.00009919944,0.30107626,0.000039571405,0.18341306,0.00044768577],"about_ca_topic_score_codex":0.000010115303,"about_ca_topic_score_gemma":0.0010293735,"teacher_disagreement_score":0.6436716,"about_ca_system_score_codex":0.000001937018,"about_ca_system_score_gemma":0.000030587977,"threshold_uncertainty_score":0.25814635},"labels":[],"label_agreement":null},{"id":"W2017096286","doi":"10.4161/hv.7.12.18322","title":"Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared to the licensed 3-dose schedule","year":2011,"lang":"en","type":"article","venue":"Human Vaccines","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":194,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; University of Alberta","funders":"Merck","keywords":"Medicine; Immunogenicity; Schedule; Titer; Internal medicine; Vaccination; Gastroenterology; Antigen; Antibody; Immunology","score_opus":0.08895439800482836,"score_gpt":0.3512983015467438,"score_spread":0.26234390354191545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017096286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9758766,0.0016765363,0.00001649219,0.0024637394,0.00014643105,0.0015285638,0.000033972858,0.00006765782,0.018189983],"genre_scores_gemma":[0.99610376,0.00008577582,0.0001570246,0.0011200523,0.00024735407,0.000068094014,0.00002785617,0.000048289665,0.0021418114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99764764,0.00018962398,0.0006629394,0.00048421058,0.0004991105,0.0005164914],"domain_scores_gemma":[0.9975923,0.00012338514,0.00018166288,0.0012685345,0.0005142307,0.0003199222],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005528232,0.00032351213,0.00068107585,0.00014393125,0.00045707313,0.000040867362,0.0006123102,0.00012500098,0.014834038],"category_scores_gemma":[0.00034446828,0.00018734252,0.0002281,0.0005983757,0.000103135346,0.00008935809,0.0005833828,0.00047602138,0.000100247715],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13656452,0.008358134,0.46266425,0.0036142939,0.003994772,0.0001882657,0.030153133,0.00001673768,0.18785726,0.013443411,0.06552541,0.0876198],"study_design_scores_gemma":[0.009252402,0.0008961519,0.95817465,0.000097528,0.00020786616,0.00007290703,0.0008637692,0.00009793056,0.021557482,0.00031204644,0.00822839,0.00023888337],"about_ca_topic_score_codex":0.0010199202,"about_ca_topic_score_gemma":0.0019446189,"teacher_disagreement_score":0.4955104,"about_ca_system_score_codex":0.00009188864,"about_ca_system_score_gemma":0.00019027236,"threshold_uncertainty_score":0.9860665},"labels":[],"label_agreement":null},{"id":"W2035039470","doi":"10.4161/hv.1.4.1971","title":"Canadian Association for Immunization Research and Evaluation (CAIRE) Guidelines for Industry Sponsored Clinical Trial and Epidemiology Contract Research","year":2005,"lang":"en","type":"article","venue":"Human Vaccines","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Wyeth Pharmaceuticals","keywords":"Epidemiology; Protocol (science); Clinical trial; Association (psychology); Medicine; Immunization; Family medicine; Public health; Environmental health; Business; Alternative medicine; Pathology; Immunology; Psychology","score_opus":0.70834095780831,"score_gpt":0.6420046208395551,"score_spread":0.06633633696875485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035039470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94155675,0.0011487164,0.000024904664,0.053348456,0.00025986668,0.0028831898,0.000017380089,0.000022773265,0.00073794305],"genre_scores_gemma":[0.98790693,0.0006686516,0.00062517397,0.00037076033,0.0052550957,0.00036070746,0.00008342847,0.00001871916,0.004710544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950435,0.0027056523,0.00078010955,0.00039249135,0.00039448083,0.0006837784],"domain_scores_gemma":[0.9859882,0.008295807,0.00019903098,0.0001836007,0.00508462,0.00024875975],"candidate_categories":["metaresearch","sts"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.064870074,0.00010074495,0.00032718913,0.00034990037,0.0022421388,0.00012989395,0.00018331513,0.00067499524,0.00010597307],"category_scores_gemma":[0.07679698,0.00009868356,0.00005864364,0.00027429796,0.00004120707,0.00032010715,0.000035811372,0.00046704625,0.00000399841],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038482295,0.00016673414,0.61766416,0.00003582676,0.000092283844,6.518426e-7,0.0026549355,0.000017673887,0.00007611942,0.06068343,0.24787624,0.06688375],"study_design_scores_gemma":[0.032555774,0.0013818421,0.5632771,0.00007285846,0.00008535617,9.996614e-7,0.0022805585,0.0030491494,0.000017993121,0.062143322,0.33482516,0.00030984188],"about_ca_topic_score_codex":0.035423428,"about_ca_topic_score_gemma":0.53917736,"teacher_disagreement_score":0.50375396,"about_ca_system_score_codex":0.0006230219,"about_ca_system_score_gemma":0.0010291584,"threshold_uncertainty_score":0.9990568},"labels":[],"label_agreement":null},{"id":"W2035983041","doi":"10.4161/hv.4.3.5686","title":"The potential cost-effectiveness of vaccination against herpes zoster and post-herpetic neuralgia","year":2008,"lang":"en","type":"article","venue":"Human Vaccines","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval","funders":"Merck Canada; Université Laval; GlaxoSmithKline","keywords":"Medicine; Vaccination; Cost effectiveness; Population; Quality-adjusted life year; Vaccine efficacy; Pediatrics; Cohort; Environmental health; Immunology; Internal medicine","score_opus":0.023855172607118853,"score_gpt":0.29800767275606166,"score_spread":0.2741525001489428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035983041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973449,0.0004870843,0.00002745032,0.00016893174,0.00014143654,0.00066929124,0.000005126427,0.000043333563,0.001112434],"genre_scores_gemma":[0.9988145,0.0002812071,0.000023807748,0.00006155784,0.000075559736,0.00005921907,0.000024454508,0.000020883781,0.0006387778],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991891,0.00010699268,0.0002202161,0.00018745824,0.00013013605,0.00016610486],"domain_scores_gemma":[0.9992961,0.000116114286,0.000082104016,0.00022874914,0.00021192199,0.000064996966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014847502,0.00014640776,0.0002256357,0.00008611475,0.00044944772,0.000018587642,0.00004945159,0.00006141929,0.00006890906],"category_scores_gemma":[0.000044038177,0.000094085815,0.00008038751,0.00011608204,0.00004190423,0.00009717994,0.000035824985,0.00007662241,0.000013755768],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018403039,0.0019605397,0.3540874,0.00083429343,0.0009973181,0.00037269318,0.00087462267,0.00006833343,0.062187094,0.0011049544,0.0009473156,0.5747251],"study_design_scores_gemma":[0.0026734632,0.00032706052,0.98790354,0.0000695278,0.000104166524,0.00017451048,0.000046822188,0.00007055566,0.0056668255,0.00011152523,0.0027586005,0.00009341606],"about_ca_topic_score_codex":0.000071794864,"about_ca_topic_score_gemma":0.000031461903,"teacher_disagreement_score":0.6338161,"about_ca_system_score_codex":0.000035010784,"about_ca_system_score_gemma":0.000028165849,"threshold_uncertainty_score":0.38367084},"labels":[],"label_agreement":null},{"id":"W2040474024","doi":"10.4161/hv.5.11.9309","title":"In Memoriam, Bernard Duval (1949 – 2008)","year":2009,"lang":"en","type":"article","venue":"Human Vaccines","topic":"Travel-related health issues","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de Santé Publique du Québec","funders":"","keywords":"Philosophy; Medicine","score_opus":0.02820136364870216,"score_gpt":0.35562245612380156,"score_spread":0.3274210924750994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040474024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9670622,0.001446545,0.000004296593,0.016112972,0.00085487956,0.00043939322,0.0000019791853,0.00017997566,0.013897777],"genre_scores_gemma":[0.9851524,0.00013685484,0.0004548255,0.0024785318,0.0020010653,0.000009032287,0.000016293516,0.000028976732,0.009722006],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9985723,0.000035158384,0.00044535447,0.00030041044,0.00022428036,0.00042251457],"domain_scores_gemma":[0.9992725,0.000029469942,0.00008082351,0.00036012282,0.000072776675,0.0001842787],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019353973,0.00019177371,0.00041190523,0.00025610693,0.00008698133,0.000013797074,0.00011555176,0.00016908211,0.00112178],"category_scores_gemma":[0.00006585541,0.0001703153,0.00006493389,0.00025111772,0.00001319273,0.00011713043,0.000017038159,0.0003704251,0.00038927255],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001080726,0.001707458,0.241017,0.0004921742,0.00012791548,0.0023892315,0.006082148,0.000038463648,0.022196755,0.013109948,0.7019216,0.009836593],"study_design_scores_gemma":[0.003726524,0.00058750587,0.92916113,0.00021134228,0.000048193597,0.000104351224,0.00007423986,0.00002705556,0.0011221912,0.0025732976,0.062159404,0.00020479184],"about_ca_topic_score_codex":0.00020250774,"about_ca_topic_score_gemma":0.00020632324,"teacher_disagreement_score":0.6881441,"about_ca_system_score_codex":0.000091408714,"about_ca_system_score_gemma":0.00005609659,"threshold_uncertainty_score":0.9997913},"labels":[],"label_agreement":null},{"id":"W2043876053","doi":"10.4161/hv.6.12.12917","title":"Searching for the Holy Grail of a staphylococcal vaccine","year":2010,"lang":"en","type":"review","venue":"Human Vaccines","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Optech (Canada)","funders":"","keywords":"Holy Grail; Staphylococcus aureus; Immunology; Colonization; Medicine; Staphylococcal infections; Virology; Microbiology; Biology; Computer science; Bacteria","score_opus":0.07428239513320778,"score_gpt":0.39652541617909515,"score_spread":0.32224302104588737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043876053","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010671155,0.9933428,0.00022841079,0.00015308669,0.0003646255,0.0041884333,0.00014552388,0.000082019396,0.0004279876],"genre_scores_gemma":[0.0006616139,0.99423796,0.00076891057,0.000071995884,0.0013939777,0.00041140566,0.00016640716,0.00020429131,0.0020834163],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99714005,0.000089205554,0.001218015,0.00061164936,0.00034946486,0.0005915993],"domain_scores_gemma":[0.9961755,0.0011714728,0.00077905913,0.0013086136,0.0004052322,0.00016010055],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00068983104,0.00066024903,0.002760671,0.00037852037,0.00034343507,0.000054733577,0.00073054445,0.00047929084,0.00020956877],"category_scores_gemma":[0.00048430802,0.00038745222,0.0014961859,0.0004553117,0.00010574928,0.000059106493,0.00018628164,0.0012267942,0.000023846313],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016841304,0.0001962901,0.000090819114,0.042786483,0.0006024228,0.000018625798,0.0001089952,3.5558122e-7,0.0016391048,0.0022329318,0.010526991,0.9416286],"study_design_scores_gemma":[0.0011125092,0.0002498647,0.00058845384,0.009715897,0.0022480013,0.00005187152,0.00002959421,0.0000033947194,0.000057229878,0.00017830747,0.98541206,0.00035281447],"about_ca_topic_score_codex":0.00005466439,"about_ca_topic_score_gemma":0.00012009553,"teacher_disagreement_score":0.97488505,"about_ca_system_score_codex":0.00006389156,"about_ca_system_score_gemma":0.0004087444,"threshold_uncertainty_score":0.9998577},"labels":[],"label_agreement":null},{"id":"W2048546608","doi":"10.4161/hv.6.8.12299","title":"Development of a Chlamydia trachomatis T cell Vaccine","year":2010,"lang":"en","type":"review","venue":"Human Vaccines","topic":"Reproductive tract infections research","field":"Immunology and Microbiology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Centre for Disease Control","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health","keywords":"Chlamydia trachomatis; Immunology; Immunity; Antigen; Chlamydia; Biology; Immune system; Intracellular parasite; Virology; Cellular immunity; Acquired immune system","score_opus":0.06287883281366984,"score_gpt":0.36704394158064896,"score_spread":0.3041651087669791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048546608","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0076325345,0.98724526,0.000011184927,0.000003825758,0.00062410283,0.0009866374,0.00002589431,0.00008972078,0.0033808227],"genre_scores_gemma":[0.0003749709,0.987729,0.00056732685,0.0000021269855,0.00016827795,0.00029681931,0.00046418386,0.00009016032,0.010307094],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974378,0.00024285955,0.0011785858,0.0006384157,0.00006574845,0.00043663703],"domain_scores_gemma":[0.99796635,0.00020005865,0.000617863,0.00095611735,0.00022728877,0.000032331714],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005460706,0.00050331035,0.0018107633,0.0006809238,0.00031907245,0.000019780513,0.0006019603,0.00081934605,0.003840217],"category_scores_gemma":[0.000118719094,0.00038878358,0.00039310587,0.0003817502,0.000053537144,0.00008517618,0.00018844457,0.0013594412,0.001850498],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000071813224,0.00046318356,0.00008892701,0.007783783,0.00034420582,0.0000027760705,0.00023085206,4.0875204e-8,0.011849305,0.000113912356,0.0019813657,0.97713447],"study_design_scores_gemma":[0.0004394477,0.00004016565,0.001370872,0.0011665034,0.00026233756,0.000105160994,0.000015007672,1.0160888e-8,0.0056071887,0.000016845237,0.9906321,0.00034432224],"about_ca_topic_score_codex":0.000022856377,"about_ca_topic_score_gemma":0.00008977175,"teacher_disagreement_score":0.9886508,"about_ca_system_score_codex":0.00007078572,"about_ca_system_score_gemma":0.00038698807,"threshold_uncertainty_score":0.9998564},"labels":[],"label_agreement":null},{"id":"W2049906117","doi":"10.4161/hv.5.3.7557","title":"AIDS Vaccine 2008 Conference","year":2009,"lang":"en","type":"article","venue":"Human Vaccines","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"","keywords":"Hogan; Library science; Human immunodeficiency virus (HIV); Political science; Government (linguistics); Medicine; Family medicine; Sociology","score_opus":0.037078292322065005,"score_gpt":0.3262082186977579,"score_spread":0.2891299263756929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049906117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8549465,0.0007912811,0.00015142949,0.006504696,0.0002680723,0.00025773657,0.0000024085753,0.00032499558,0.13675287],"genre_scores_gemma":[0.9825321,0.00022273698,0.00017298434,0.00095739955,0.0010650596,0.0000055933074,0.0000074200066,0.000010607503,0.015026126],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9986739,0.00008649896,0.00026487932,0.0002838774,0.00025313377,0.00043769355],"domain_scores_gemma":[0.99922115,0.00003955454,0.00008845776,0.00029312223,0.00019767179,0.0001600489],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002833406,0.00016472807,0.0002456231,0.00011728943,0.00082159985,0.00013716819,0.00039661763,0.00010189534,0.0044485186],"category_scores_gemma":[0.000103121914,0.00015510277,0.00009056945,0.0003002292,0.000005908603,0.0003957925,0.000026446696,0.00013701229,0.00026393685],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062189254,0.00034882562,0.124365754,0.000019580086,0.00003907808,0.0000802174,0.011809033,0.000005518509,0.004667221,0.5364044,0.2820002,0.04019799],"study_design_scores_gemma":[0.0017304124,0.0005250241,0.6799223,0.00007133666,0.000054461354,0.0000067470937,0.0018910347,0.000010054925,0.00064101367,0.07091212,0.24354959,0.0006859495],"about_ca_topic_score_codex":0.00028160537,"about_ca_topic_score_gemma":0.0017050941,"teacher_disagreement_score":0.55555654,"about_ca_system_score_codex":0.00004301792,"about_ca_system_score_gemma":0.00008771269,"threshold_uncertainty_score":0.9964616},"labels":[],"label_agreement":null},{"id":"W2057104007","doi":"10.4161/hv.7.6.15007","title":"Increasing pandemic vaccination rates with effective communication","year":2011,"lang":"en","type":"article","venue":"Human Vaccines","topic":"Misinformation and Its Impacts","field":"Social Sciences","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Providence Health Care; Centre for Health Evaluation and Outcome Sciences","funders":"","keywords":"Public health; Pandemic; Public relations; Vaccination; Health communication; Information Dissemination; Social media; Internet privacy; Medicine; Business; Coronavirus disease 2019 (COVID-19); Political science; Disease; Infectious disease (medical specialty); Computer science; Immunology; Nursing","score_opus":0.05845645706609882,"score_gpt":0.3460264004311486,"score_spread":0.28756994336504976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057104007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.874556,0.00009055019,0.00008726016,0.00008154012,0.000025479481,0.0002745702,4.7076824e-7,0.00012351338,0.12476058],"genre_scores_gemma":[0.99896663,0.000119079974,0.0003321246,0.000104084385,0.00005018223,0.0000072684843,0.000010091087,0.000006852044,0.0004036657],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992322,0.0002778112,0.00013081719,0.00007584964,0.00013816374,0.00014518482],"domain_scores_gemma":[0.9993953,0.00010395351,0.00012259417,0.00015982632,0.00015390574,0.00006443213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079967413,0.00007353094,0.000087671906,0.00008891244,0.0006885548,0.000068477726,0.00016188608,0.00004942685,0.0008754947],"category_scores_gemma":[0.00018242445,0.00005880857,0.000018107245,0.00018113288,0.000027331884,0.0007246903,0.000020056299,0.00007185528,0.00004820704],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020718283,0.00013934427,0.4852336,0.00004945978,0.00005400011,0.0000010096088,0.38203862,0.0000042333445,0.00047810527,0.07715496,0.0018167488,0.052822743],"study_design_scores_gemma":[0.00048765604,0.00006391647,0.9861257,0.00003614793,0.000013853442,0.000003087788,0.008385431,0.00001734134,0.00037646416,0.0019613162,0.0024108218,0.000118233016],"about_ca_topic_score_codex":0.002242933,"about_ca_topic_score_gemma":0.0027361047,"teacher_disagreement_score":0.5008921,"about_ca_system_score_codex":0.00006148402,"about_ca_system_score_gemma":0.000029981025,"threshold_uncertainty_score":0.9586053},"labels":[],"label_agreement":null},{"id":"W2064091377","doi":"10.4161/hv.1.1.1553","title":"A Phase I, Randomized, Controlled Trial to Study the Reactogenicity and Immunogenicity of a Nasal, Inactivated Trivalent Influenza Virus Vaccine in Healthy Adults","year":2005,"lang":"en","type":"article","venue":"Human Vaccines","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Reactogenicity; Immunogenicity; Medicine; Virology; Nasal administration; Trivalent influenza vaccine; Influenza vaccine; Virus; Influenza A virus; Randomized controlled trial; Immunology; Internal medicine; Antibody","score_opus":0.07541509844375696,"score_gpt":0.42656770876693034,"score_spread":0.35115261032317335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064091377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9721219,0.004230401,0.000004114399,0.0011606114,0.0000688836,0.022242023,0.000014544882,0.000060667004,0.000096869306],"genre_scores_gemma":[0.9958625,0.0004128961,0.00004396294,0.0012141264,0.00030246377,0.0020888827,0.0000041689914,0.000038176266,0.000032860087],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.994923,0.0011272207,0.0021465116,0.00055181683,0.00066818256,0.0005832781],"domain_scores_gemma":[0.9966252,0.0013282687,0.000543299,0.00072975946,0.00050833076,0.00026517242],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0036572907,0.00044807408,0.0031743748,0.000589075,0.00029830693,0.000032381507,0.00028544583,0.00011151608,0.00015003124],"category_scores_gemma":[0.0056007127,0.00026171358,0.00038166804,0.0006413393,0.00008490907,0.00014801201,0.00028975843,0.00053535175,0.000010198909],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9754758,0.0075816843,0.0021926735,0.00006836101,0.0013777688,0.000014832526,0.005188469,0.00000991312,0.0066269576,0.000025696243,0.00013368075,0.0013041524],"study_design_scores_gemma":[0.9714593,0.01072245,0.013747132,0.00010378738,0.00044612878,0.0000069253465,0.0010140724,0.00014269436,0.0018697372,0.000020234647,0.0002537167,0.00021380036],"about_ca_topic_score_codex":0.0023807476,"about_ca_topic_score_gemma":0.0016405138,"teacher_disagreement_score":0.023740577,"about_ca_system_score_codex":0.00018332372,"about_ca_system_score_gemma":0.00018057843,"threshold_uncertainty_score":0.9999835},"labels":[],"label_agreement":null},{"id":"W2065739755","doi":"10.4161/hv.6.12.13399","title":"Correlation between levels of human papillomavirus (HPV)-16 and 18 antibodies in serum and cervicovaginal secretions in girls and women vaccinated with the HPV-16/18 AS04-adjuvanted vaccine","year":2010,"lang":"en","type":"article","venue":"Human Vaccines","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"GlaxoSmithKline","keywords":"Antibody; Medicine; Titer; Vaccination; Antibody titer; Immunology; Correlation","score_opus":0.040306430003011186,"score_gpt":0.3432970642834369,"score_spread":0.3029906342804257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065739755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99510205,0.000722482,0.000013837826,0.0009070182,0.000023352195,0.00069813605,0.00004498367,0.000036360285,0.002451784],"genre_scores_gemma":[0.99891734,0.00014746441,0.000021429676,0.00009399535,0.00013765025,0.00004192966,0.00006770295,0.000035672623,0.00053682993],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825317,0.00010257927,0.00047721222,0.0004409637,0.000283256,0.0004428095],"domain_scores_gemma":[0.998933,0.00017800293,0.00013689024,0.0003333379,0.00023725902,0.00018147542],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00058974524,0.00028030382,0.00066481304,0.00046521914,0.0002544839,0.000060714836,0.00011732348,0.00016367626,0.0041436716],"category_scores_gemma":[0.00006309263,0.00019276734,0.000028327997,0.0005256867,0.00011317901,0.00020990163,0.00016338367,0.0006991997,0.000001968729],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040704614,0.000099652556,0.9822082,0.000356479,0.00006061839,0.000015277037,0.0013560107,0.0000010687185,0.004480107,0.00029395585,0.00018722774,0.010534375],"study_design_scores_gemma":[0.007681533,0.0008558283,0.9880274,0.00007146372,0.00007490351,0.000038859875,0.00068373064,0.00006821035,0.0007482207,0.0013133531,0.00022329498,0.00021321833],"about_ca_topic_score_codex":0.0009964056,"about_ca_topic_score_gemma":0.012350686,"teacher_disagreement_score":0.011354281,"about_ca_system_score_codex":0.00007729461,"about_ca_system_score_gemma":0.0000555033,"threshold_uncertainty_score":0.9967667},"labels":[],"label_agreement":null},{"id":"W2073044683","doi":"10.4161/hv.5.2.7210","title":"BCG Vaccines: Their mechanisms of attenuation and impact on safety and protective efficacy","year":2009,"lang":"en","type":"review","venue":"Human Vaccines","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research; National Natural Science Foundation of China","keywords":"Virulence; Mycobacterium bovis; Mycobacterium tuberculosis; BCG vaccine; Tuberculosis vaccines; Tuberculosis; Tuberculin; Attenuated vaccine; Biology; Virology; Immunization; Immunology; Vaccination; Microbiology; Medicine; Immune system; Genetics; Gene","score_opus":0.07193749844206884,"score_gpt":0.40676095174401117,"score_spread":0.3348234533019423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073044683","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004426654,0.9912718,0.0000922516,0.0004156781,0.00003485159,0.0031552387,0.00005874731,0.000056829213,0.0004879648],"genre_scores_gemma":[0.0067440746,0.9923506,0.00007941185,0.0001035745,0.0002705088,0.000068629335,0.00019258333,0.000052596504,0.00013803483],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976784,0.0004198962,0.000765851,0.0005724476,0.00017951273,0.00038387862],"domain_scores_gemma":[0.9981051,0.00064707454,0.00040599177,0.00046317402,0.00015278166,0.0002258469],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007475646,0.0005306036,0.0026979414,0.0004648005,0.00012950898,0.000015877706,0.00012343391,0.00037726047,0.00010457961],"category_scores_gemma":[0.00067343906,0.0002997066,0.00035891045,0.00024034717,0.00003486685,0.00005836947,0.000076437165,0.00054981874,0.00001187872],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041947557,0.000170274,0.0001167318,0.0061238506,0.0004974317,0.000011160205,0.00008736327,8.4890377e-7,0.00007585792,0.00077076704,0.00070296554,0.9910233],"study_design_scores_gemma":[0.015727693,0.031322043,0.3499225,0.08351453,0.005985622,0.001972817,0.00026769706,0.00016223962,0.00022411614,0.01792299,0.49015003,0.0028277088],"about_ca_topic_score_codex":0.000077198376,"about_ca_topic_score_gemma":0.000019076879,"teacher_disagreement_score":0.98819554,"about_ca_system_score_codex":0.00011064074,"about_ca_system_score_gemma":0.00011019291,"threshold_uncertainty_score":0.9999455},"labels":[],"label_agreement":null},{"id":"W2074911236","doi":"10.4161/hv.4.1.4778","title":"Antibody gene-based prophylaxis and therapy for biodefence","year":2008,"lang":"en","type":"article","venue":"Human Vaccines","topic":"Bacillus and Francisella bacterial research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Defence Research and Development Canada","funders":"","keywords":"Antibody; Genetic enhancement; Immunology; Passive immunity; Vaccination; Immunity; Immune system; Medicine; In vivo; Biology; Gene delivery; Transgene; Vectors in gene therapy; Virology; Gene; Vector (molecular biology); Biotechnology; Recombinant DNA; Genetics","score_opus":0.03448213629659268,"score_gpt":0.3098413044306517,"score_spread":0.27535916813405903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074911236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966199,0.001764891,0.0010592937,0.00004648064,0.00005147231,0.00030752737,0.00002142757,0.0000099602275,0.00011909402],"genre_scores_gemma":[0.99771947,0.000766163,0.0004903573,0.000099635916,0.00028973393,0.00004107878,0.00017707131,0.000016857768,0.00039961425],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99936414,0.000018690831,0.00010407128,0.00026194725,0.000063602434,0.00018752711],"domain_scores_gemma":[0.9995964,0.000008938227,0.000029001048,0.00020374285,0.00010580708,0.000056116416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008584635,0.000106199885,0.00010574465,0.000031977757,0.00022211573,0.000018773464,0.000107648055,0.00008357891,0.000026278944],"category_scores_gemma":[0.000027629092,0.00008524757,0.000051192987,0.000043665277,0.00005685485,0.0000023326395,0.000028581855,0.00003327362,0.0000026331898],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017785675,0.000040972416,0.013118062,0.000016943384,0.000010894058,0.0000014109697,0.000018513605,0.0000011779462,0.98350203,0.000015450023,0.00028802507,0.0028086444],"study_design_scores_gemma":[0.0022555927,0.0017609646,0.06936721,0.000006307391,0.0000033945876,0.000014305487,0.0000059071494,0.000044428412,0.8847071,0.00009850069,0.041487306,0.0002490038],"about_ca_topic_score_codex":0.000014502149,"about_ca_topic_score_gemma":0.0000066825396,"teacher_disagreement_score":0.09879497,"about_ca_system_score_codex":0.0000023902671,"about_ca_system_score_gemma":0.00003962424,"threshold_uncertainty_score":0.3476295},"labels":[],"label_agreement":null},{"id":"W2085552858","doi":"10.4161/hv.5.5.7442","title":"Vaccines targeting IgE in the treatment of asthma and allergy","year":2009,"lang":"en","type":"review","venue":"Human Vaccines","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Children's Hospital Research Institute of Manitoba; Manitoba Health","funders":"","keywords":"Omalizumab; Immunoglobulin E; Medicine; Asthma; Immunology; Allergy; Anaphylaxis; Adverse effect; Antibody; Pharmacology","score_opus":0.04369772046502389,"score_gpt":0.34827579179000995,"score_spread":0.30457807132498604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085552858","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007362255,0.9910706,3.693411e-7,0.000055202847,0.000051398474,0.0008383278,0.000010294511,0.000026524298,0.00058499153],"genre_scores_gemma":[0.00089528895,0.9975804,0.000023831455,0.00007142355,0.00072345143,0.0000754698,0.000111926056,0.000038375532,0.00047983255],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99837637,0.00015896537,0.0006926823,0.00035520832,0.00017026206,0.00024654216],"domain_scores_gemma":[0.99905217,0.00011863034,0.0002971886,0.00039558575,0.000049966566,0.000086474734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012655069,0.00044150164,0.0016700578,0.00025889048,0.0000928618,0.000018354642,0.00014658632,0.00017151766,0.00013348093],"category_scores_gemma":[0.000031256975,0.00022226217,0.00040344836,0.00022092041,0.000022674627,0.000036118185,0.000020198046,0.00012457163,0.0000074487048],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024111047,0.0006368409,0.0006386194,0.0048502763,0.0001245152,0.00013877763,0.00029351632,2.707007e-7,0.000003148407,0.00007647677,0.0017526431,0.9914608],"study_design_scores_gemma":[0.000911661,0.00097526493,0.0064196177,0.003880618,0.00039057244,0.000061126455,0.00012343569,7.3262885e-7,0.0000017061476,0.000024027318,0.9870192,0.00019207188],"about_ca_topic_score_codex":0.000029192257,"about_ca_topic_score_gemma":0.000052822736,"teacher_disagreement_score":0.99126875,"about_ca_system_score_codex":0.000043242693,"about_ca_system_score_gemma":0.00009337354,"threshold_uncertainty_score":0.90635884},"labels":[],"label_agreement":null},{"id":"W2086311575","doi":"10.4161/hv.1.6.2377","title":"Safety and Immunogenicity of Two Formulations of a Hexavalent Diphtheria-Tetanus-Acellular Pertussis-Inactivated Poliovirus-<i>Haemophilus influenzae</i>b Conjugate-Hepatitis B Vaccine in 15 to 18 Month-Old Children","year":2005,"lang":"en","type":"article","venue":"Human Vaccines","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Diphtheria; Immunogenicity; Medicine; Virology; Tetanus; Haemophilus influenzae; Conjugate vaccine; Poliovirus; Immunization; Vaccination; Microbiology; Immunology; Antibody; Antibiotics; Virus; Biology","score_opus":0.020272946423950115,"score_gpt":0.2904327260510381,"score_spread":0.270159779627088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086311575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99450064,0.0025328968,0.000044402044,0.0006253116,0.000046728,0.0014037227,0.00016784274,0.00007269565,0.00060577394],"genre_scores_gemma":[0.9972704,0.0009656777,0.00082503457,0.00034904518,0.00016633072,0.000049726536,0.00006452185,0.00006666305,0.00024258884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99719685,0.000109847635,0.0013640417,0.0004901753,0.00035976362,0.00047934294],"domain_scores_gemma":[0.9983025,0.000111814756,0.00038274153,0.00067011954,0.00033215818,0.00020064057],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003065908,0.0004305523,0.0012456994,0.00049914524,0.00018649727,0.00001581173,0.00019550827,0.00012794964,0.00046005033],"category_scores_gemma":[0.00024289273,0.00039279932,0.00017154495,0.00059492525,0.000064908396,0.00024661928,0.00024592367,0.00022774962,0.000013868466],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008687636,0.00040383855,0.8812279,0.000112945134,0.00033783427,0.000010265074,0.0015299838,0.00012766685,0.1135983,0.0005188649,0.00020326689,0.0010603539],"study_design_scores_gemma":[0.007099909,0.0006393596,0.9501023,0.00036468342,0.00021299985,0.000035934238,0.000036564827,0.00017605558,0.04034373,0.00015556878,0.0005036038,0.0003292633],"about_ca_topic_score_codex":0.026436597,"about_ca_topic_score_gemma":0.019917382,"teacher_disagreement_score":0.07325457,"about_ca_system_score_codex":0.00021377593,"about_ca_system_score_gemma":0.00006577297,"threshold_uncertainty_score":0.9998524},"labels":[],"label_agreement":null},{"id":"W2087412934","doi":"10.4161/hv.1.5.2079","title":"Safety and Immunogenicity of a Pentavalent Combination Vaccine (Diphtheria, Tetanus, Acellular Pertussis, Polio and Haemophilus Influenzae Type b Conjugate) When Administered as a Fourth Dose at 15 to 18 Months of Age","year":2005,"lang":"en","type":"article","venue":"Human Vaccines","topic":"Bacterial Infections and Vaccines","field":"Immunology and Microbiology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Children's Hospital","funders":"Sanofi Pasteur","keywords":"Medicine; Tetanus; Diphtheria; Booster dose; Poliomyelitis; Vaccination; Immunogenicity; Immunization; Immunology; Vaccination schedule; Adverse effect; Conjugate vaccine; Haemophilus influenzae; Hib vaccine; Pediatrics; Internal medicine; Antibody; Antibiotics","score_opus":0.02343117416936941,"score_gpt":0.27510803242843257,"score_spread":0.25167685825906316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087412934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99342674,0.004938547,0.0000049924265,0.00042706906,0.00022918911,0.0005746875,0.00005820011,0.00003898476,0.00030158448],"genre_scores_gemma":[0.9966499,0.0004411299,0.0000690407,0.00009928285,0.00005797257,0.000012627892,0.00011298164,0.00002727554,0.0025297457],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99853057,0.00014842831,0.0006774739,0.00034633192,0.00003497964,0.00026220822],"domain_scores_gemma":[0.9989929,0.00006763128,0.0003044459,0.00038011756,0.00019543071,0.000059445516],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021608044,0.00027967975,0.000616849,0.00021454997,0.00025835691,0.000023057331,0.00015721892,0.00020005397,0.0018542629],"category_scores_gemma":[0.000070677204,0.00024368502,0.000085696905,0.00013642367,0.000058259677,0.00014136851,0.0002763696,0.000107115,0.00003013619],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028312241,0.00036100135,0.026264675,0.00009109688,0.00033243393,0.0000026941693,0.0016378958,0.000005622634,0.96492326,0.00052969734,0.0010583884,0.0019620338],"study_design_scores_gemma":[0.012798832,0.0029415435,0.7311032,0.00019074217,0.00037161977,0.0003022986,0.00031165886,0.000013372262,0.1847556,0.00037792278,0.066236444,0.00059676723],"about_ca_topic_score_codex":0.0012392061,"about_ca_topic_score_gemma":0.001524852,"teacher_disagreement_score":0.78016764,"about_ca_system_score_codex":0.000052557254,"about_ca_system_score_gemma":0.000030518437,"threshold_uncertainty_score":0.9990582},"labels":[],"label_agreement":null},{"id":"W2091731210","doi":"10.4161/hv.6.10.13018","title":"Dengue vaccine trial guidelines and role of large-scale, post proof-of-concept demonstration projects in bringing a dengue vaccine to use in dengue endemic areas","year":2010,"lang":"en","type":"review","venue":"Human Vaccines","topic":"Mosquito-borne diseases and control","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brock University","funders":"","keywords":"Dengue vaccine; Dengue fever; Context (archaeology); Clinical trial; Medicine; Meaning (existential); Dengue virus; Immunology; Psychology; Geography; Pathology","score_opus":0.04870869317239846,"score_gpt":0.3570735335645766,"score_spread":0.30836484039217815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091731210","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3804542,0.61310476,0.00003408275,0.00007691174,0.0001958448,0.005945228,0.00011504033,0.000048062204,0.00002586029],"genre_scores_gemma":[0.5733636,0.4172054,0.0014992001,0.0003291366,0.0032907526,0.002032428,0.0014105054,0.00045460075,0.00041438907],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9944059,0.00026534623,0.003069804,0.0010947314,0.00043972474,0.00072447065],"domain_scores_gemma":[0.99660283,0.00033014617,0.0010806596,0.00094607536,0.0007077832,0.00033249732],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00090269634,0.00090076163,0.0037656808,0.00149915,0.000084036306,0.00006010154,0.00040613321,0.00068136305,0.000104490275],"category_scores_gemma":[0.0019333694,0.0007538345,0.00054094975,0.0009165612,0.00001818608,0.00027388326,0.00022480357,0.00088526175,0.0000023622729],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00546194,0.0022228,0.08708793,0.021625323,0.00049927854,0.0002233342,0.0015131553,0.000028770168,0.0013805793,0.0003248708,0.0006917045,0.87894034],"study_design_scores_gemma":[0.27757776,0.005899094,0.21205302,0.19453724,0.016228678,0.0013417057,0.0036485922,0.003058451,0.002348584,0.00038608056,0.27590874,0.0070120813],"about_ca_topic_score_codex":0.0009927095,"about_ca_topic_score_gemma":0.014024499,"teacher_disagreement_score":0.8719282,"about_ca_system_score_codex":0.00011176202,"about_ca_system_score_gemma":0.00063496607,"threshold_uncertainty_score":0.9994913},"labels":[],"label_agreement":null},{"id":"W2114391710","doi":"10.4161/hv.5.10.9518","title":"Comparison of the immunogenicity and safety of<i>Cervarix</i>™ and<i>Gardasil</i><sup>®</sup>human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18–45 years","year":2009,"lang":"en","type":"article","venue":"Human Vaccines","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":401,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Gardasil; Medicine; Vaccination; Immunogenicity; HPV vaccines; Cervical cancer; Titer; Cohort; HPV infection; Virology; Immunology; Cancer; Internal medicine; Antibody","score_opus":0.045839521729254096,"score_gpt":0.37828132876353293,"score_spread":0.33244180703427884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114391710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99037117,0.0064822366,0.0000017934331,0.0010467215,0.00004244233,0.00070311356,0.000030581716,0.0000316271,0.001290335],"genre_scores_gemma":[0.99778515,0.0010092013,0.000027996442,0.000640129,0.00017854436,0.00003798627,0.000013058694,0.000028335571,0.000279618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974273,0.00019571191,0.00089979783,0.00044885374,0.0004781274,0.0005502442],"domain_scores_gemma":[0.9986962,0.00012254054,0.00020966063,0.0005517278,0.00017456328,0.00024528868],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00053855707,0.0002783407,0.0010663589,0.00019727024,0.00022124246,0.00002504227,0.00029247455,0.00017551168,0.0021900425],"category_scores_gemma":[0.000066769724,0.00020957044,0.00013596762,0.00048018858,0.00012029975,0.00009157595,0.00021687894,0.0005986769,0.0000018883021],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004126088,0.00063606823,0.944816,0.00070866855,0.00011981408,0.000009336998,0.0047271536,0.000046611218,0.0068820724,0.00035436015,0.00079866947,0.036775146],"study_design_scores_gemma":[0.00646153,0.0010228598,0.98885494,0.00010601948,0.00006469477,0.0000091341135,0.00055242656,0.00012055627,0.0010836131,0.00051198766,0.0010212355,0.0001910097],"about_ca_topic_score_codex":0.002152884,"about_ca_topic_score_gemma":0.0019288326,"teacher_disagreement_score":0.04403892,"about_ca_system_score_codex":0.0001793509,"about_ca_system_score_gemma":0.00014218749,"threshold_uncertainty_score":0.9987221},"labels":[],"label_agreement":null},{"id":"W2127650449","doi":"10.4161/hv.6.6.11097","title":"Recent advances in<i>Ebolavirus</i>vaccine development","year":2010,"lang":"en","type":"review","venue":"Human Vaccines","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Public Health Agency of Canada","funders":"","keywords":"Biodefense; Ebolavirus; Virology; Case fatality rate; Biology; Outbreak; Medicine; Immunology; Ebola virus; Population; Microbiology; Environmental health","score_opus":0.08233256001993501,"score_gpt":0.43321658682336983,"score_spread":0.35088402680343483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127650449","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015968163,0.9915809,0.000004671447,0.00006580944,0.00036613067,0.0012180777,0.000005707964,0.00009799346,0.0065010116],"genre_scores_gemma":[0.000011908843,0.9940721,0.00016820687,0.00006392891,0.00068646047,0.00034686533,0.0002683566,0.00009392511,0.0042882687],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973967,0.00008428993,0.0010451961,0.0006020837,0.00032833626,0.0005433685],"domain_scores_gemma":[0.9987463,0.000068060646,0.00023950821,0.0005341461,0.00019214995,0.0002198488],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040315103,0.0005353166,0.0019316641,0.0008367022,0.00020447191,0.000052475618,0.0002298871,0.0004337735,0.0017489186],"category_scores_gemma":[0.00009456889,0.00037829462,0.0002928885,0.000741538,0.000019604258,0.00015732783,0.00016757776,0.0014049828,0.00048458972],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013900462,0.0002014457,0.00020467301,0.006060455,0.000044908433,0.000062638,0.00002124685,7.2091e-8,0.000008882072,0.000056210494,0.0010432288,0.99228233],"study_design_scores_gemma":[0.0007519858,0.000115565905,0.00052447605,0.0071976925,0.0001803812,0.0001788613,0.0000070883634,5.679293e-7,0.000022196775,0.000018712753,0.99063814,0.00036431343],"about_ca_topic_score_codex":0.00001488752,"about_ca_topic_score_gemma":0.000898966,"teacher_disagreement_score":0.991918,"about_ca_system_score_codex":0.00023340675,"about_ca_system_score_gemma":0.0004863908,"threshold_uncertainty_score":0.9998669},"labels":[],"label_agreement":null},{"id":"W2152769327","doi":"10.4161/hv.5.5.7607","title":"Vaccines and vaccination strategies against human cutaneous leishmaniasis","year":2009,"lang":"en","type":"review","venue":"Human Vaccines","topic":"Research on Leishmaniasis Studies","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Vaccination; Cutaneous leishmaniasis; Immunology; Leishmaniasis; Immunity; Leishmania; Leishmania major; Immune system; Medicine; Virology; Attenuated vaccine; Disease; Biology; Virulence","score_opus":0.07216413609611459,"score_gpt":0.38866359333510864,"score_spread":0.31649945723899403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152769327","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028980754,0.97649014,0.0000033438007,0.00032556133,0.00014515316,0.0026255983,0.000027253045,0.0004980412,0.016986826],"genre_scores_gemma":[0.002685926,0.9899409,0.00012582801,0.00012290083,0.0015074866,0.00024952908,0.0004734287,0.00023926677,0.004654728],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947326,0.00031839678,0.0016480266,0.0014560277,0.00081545993,0.0010294786],"domain_scores_gemma":[0.9967033,0.00031478694,0.0007569316,0.0012315819,0.0005958175,0.00039756746],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0004792865,0.0014309564,0.004397137,0.0013174672,0.00095520896,0.0005250556,0.0005775907,0.0006562547,0.00040165015],"category_scores_gemma":[0.00029450285,0.0011267553,0.0007757366,0.000723,0.000068062385,0.00046995745,0.0003781636,0.0011407216,0.00012513767],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030216177,0.0003419474,0.0002589724,0.025136871,0.0009338366,0.000825137,0.00019671208,5.9124903e-7,0.000038049977,0.0019630976,0.01779872,0.95247585],"study_design_scores_gemma":[0.0015526271,0.0011040942,0.004373088,0.011529069,0.0019722565,0.0015303834,0.0003549159,0.0000039819192,0.000008150662,0.00091109774,0.97539467,0.0012656634],"about_ca_topic_score_codex":0.00006366405,"about_ca_topic_score_gemma":0.00038040293,"teacher_disagreement_score":0.95759594,"about_ca_system_score_codex":0.0004604435,"about_ca_system_score_gemma":0.00032984908,"threshold_uncertainty_score":0.999844},"labels":[],"label_agreement":null},{"id":"W2164293944","doi":"10.4161/hv.7.5.14819","title":"Burden of rotavirus gastroenteritis in the pediatric population in Central and Eastern Europe","year":2011,"lang":"en","type":"review","venue":"Human Vaccines","topic":"Viral gastroenteritis research and epidemiology","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Inro Consultants (Canada)","funders":"","keywords":"Rotavirus; Rotavirus gastroenteritis; Medicine; Population; Virology; Pediatrics; Geography; Environmental health; Virus","score_opus":0.09505753528006307,"score_gpt":0.3736135117448424,"score_spread":0.27855597646477936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164293944","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19886467,0.80008304,0.0000016576141,0.000042155083,0.000051129187,0.000765495,0.00001860977,0.000008146447,0.00016507374],"genre_scores_gemma":[0.11005798,0.889213,0.000027571341,0.000025116788,0.00038758566,0.00004760609,0.00012260293,0.000026814934,0.00009170658],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976981,0.0005685465,0.0008379122,0.00030468364,0.00012500673,0.00046573355],"domain_scores_gemma":[0.99934465,0.000026109497,0.00023530392,0.0002694037,0.00003435107,0.00009017457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004019316,0.00024554448,0.0013091336,0.0004202979,0.000023423649,0.000012236411,0.00021114512,0.000111277885,0.0000653725],"category_scores_gemma":[0.00015211829,0.00016349778,0.00014334833,0.00024484916,0.000028324872,0.00005853172,0.000104619896,0.0004211893,0.000006761825],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009532889,0.00012118656,0.77093005,0.01124795,0.000027339587,0.00021794469,0.00019237786,4.7426624e-7,0.0000012792269,0.00005821426,0.00026907245,0.21683876],"study_design_scores_gemma":[0.0017422723,0.0011533998,0.9377046,0.008382153,0.00026719455,0.0006767833,0.00004874143,0.000011949293,2.900352e-8,0.00005134128,0.04978366,0.00017786621],"about_ca_topic_score_codex":0.0015908345,"about_ca_topic_score_gemma":0.00046198696,"teacher_disagreement_score":0.2166609,"about_ca_system_score_codex":0.00003388464,"about_ca_system_score_gemma":0.000026321171,"threshold_uncertainty_score":0.6667246},"labels":[],"label_agreement":null},{"id":"W2416299241","doi":"10.4161/hv.7.0.14904","title":"Preface: Seventh World Congress on Vaccines, Immunisation and Immunotherapy","year":2011,"lang":"en","type":"article","venue":"Human Vaccines","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"International Civil Aviation Organization","funders":"","keywords":"Library science; Vaccination; Medicine; Political science; Family medicine; Immunology","score_opus":0.05717104425724771,"score_gpt":0.3054764996989979,"score_spread":0.2483054554417502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2416299241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98226744,0.0014181952,0.000004584662,0.0003043626,0.00032236244,0.0005166557,0.000005428092,0.00015029503,0.015010684],"genre_scores_gemma":[0.9867547,0.0006430802,0.00024117254,0.0005170078,0.00017537686,0.000057869813,0.000019315215,0.00004662588,0.011544816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893534,0.000054393655,0.0003156537,0.00028322192,0.00016372715,0.00024764007],"domain_scores_gemma":[0.9992225,0.00004762145,0.000117564836,0.00042270948,0.00011540035,0.00007419784],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015342441,0.00023592559,0.00037245505,0.00022103461,0.00025338685,0.0000213531,0.00009645909,0.0000589349,0.0011253228],"category_scores_gemma":[0.000035995738,0.00019154389,0.000060207745,0.00014817645,0.00003501297,0.0001137864,0.000058389352,0.00016523236,0.00007248173],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076458894,0.0004730992,0.9528216,0.00016075051,0.0003956107,0.0000406265,0.0040436,4.7843423e-7,0.01149217,0.004001442,0.014083268,0.011722744],"study_design_scores_gemma":[0.002469336,0.00049051543,0.9765942,0.00018454465,0.00006280901,0.000016939039,0.000091412316,0.0000097774355,0.0058028344,0.00064027536,0.01342768,0.00020964239],"about_ca_topic_score_codex":0.00074664404,"about_ca_topic_score_gemma":0.0015905309,"teacher_disagreement_score":0.023772612,"about_ca_system_score_codex":0.00004742962,"about_ca_system_score_gemma":0.000019713118,"threshold_uncertainty_score":0.9997878},"labels":[],"label_agreement":null}]}